The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in sales , its exclusivity period created a wave of generic competition , significantly diminishing its dominance. While specific businesses may try to capitalize on related treatments , the existing land